Analyst consensus rating
Rapid Micro Biosystems Analyst Rating: Strong Buy
RPID is rated Strong Buy by 3 analysts with a $6.67 target. As of 2026-08-25.
Direct answer
Rapid Micro Biosystems's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $6.67.
Forecast evidence checked August 25, 2026.
Get free Rapid Micro Biosystems email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.66
- Average price target
- $6.67
- High price target
- $8.00
- Low price target
- $5.00
- Low target gap
- +201.2%
- Target upside
- +301.6%
- High target gap
- +381.9%
- Target range width
- 180.7%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- August 25, 2026
- Valid through
- September 1, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Rapid Micro Biosystems?
Rapid Micro Biosystems has a verified Strong Buy consensus. The same dataset has an average price target of $6.67.
How far are Rapid Micro Biosystems's low and high targets from the recorded price?
The low target implies +201.2%, while the high target implies +381.9%.
How many analysts are included in Rapid Micro Biosystems's consensus?
The verified consensus includes 3 analysts.
How is Rapid Micro Biosystems's target upside or downside calculated?
The average target of $6.67 is divided by the recorded price of $1.66, then one is subtracted to produce +301.6%. This does not guarantee a future return.
When was Rapid Micro Biosystems's analyst forecast verified?
The data was verified on 2026-08-25. The dataset is valid through 2026-09-01.